CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Atopic Dermatitis (Atopic Eczema).

Jul 7, 2023 - 20:00

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Atopic Dermatitis (Atopic Eczema).

Read the original article

Tags:

Previous Article

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for Kidney Cancer (Renal Cell...

AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

CPHI Europe: Overcoming the unique challenges with high-concentration mAbs

CPHI Europe: Overcoming the unique challenges with high...

Oct 12, 2024

CHMP backs Boehringer’s Spevigo for preventing rare psoriasis flare-ups

CHMP backs Boehringer’s Spevigo for preventing rare pso...

Jul 30, 2024

For pharma companies, the possibilities of green chemistry are huge

For pharma companies, the possibilities of green chemis...

Nov 1, 2024